Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1109448 NASHVILLE, TN
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,370,302
+$693,480 QoQ
Shares Held
75,250
+58.0% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 183 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. CGEM ranks #120 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in CGEM

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,370,302 75,250
2026-03-31 $676,822 47,630
2025-12-31 $492,970 47,630
2025-09-30 $282,445 47,630
2025-06-30 $358,653 47,630
2025-03-31 $13,043,117 1,723,001
2024-12-31 $24,500,374 2,011,525
2024-09-30 $31,042,823 1,854,410
2024-06-30 $30,145,824 1,728,545
2024-03-31 $565,728 33,200
2023-12-31 $442,042 43,380
2023-09-30 $395,847 43,740
2023-06-30 $470,642 43,740
2023-03-31 $334,521 32,700
2022-12-31 $297,510 28,200
2022-09-30 $342,294 26,700
2022-06-30 $311,526 24,300
2022-03-31 $147,627 14,100
2021-12-31 $245,337 15,900
2021-09-30 $311,466 13,800
2021-06-30 $355,350 13,800